Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
AWMF (2009a) S3-Leitlinie Prophylaxe der venösen Thromboembolie. VASA 2009; S/76, vol 38: 1–131; AWMF-Register-Nr. 003/001
AWMF (2009b) S3-Leitlinie zur Hormontherapie in Peri- und Postmenopause (2009), AWMF-Register-Nr. 015/062
Bates SM, Greer IA, Pabinger I, Sofaer S, Hirsh J (2008) Venous thromboembolism, thrombophiia, antithrombotic therapy and pregnancy. ACCP Giudielines, 8th edition. Chest 133: 844S–886S
Bergqvist D, Agnelli G, Cohen AT et al. (2002) Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med 346: 975–980
Bloemenkamp KW, Rosendaal FR, Helmerhorst FM, Vandenbroucke JP (2000) Higher risk of venous thrombosis during early use of oral contraceptives in women with inherited clotting defects. Arch Intern Med 160: 49–52
Brenner B, Hoffman R, Carp H, Dulitsky M, Younis J (2005) Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study. J Thromb Haemost 3: 227–229
Canonico M, Plu-Bureau G, Lowe GD, Scarabin PY (2008) Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and metaanalysis. BMJ 336 (7655): 1227–1231
Caine GJ, Stonelake PS, Rea D, Lip GYH (2003) Coagulapathic complications in breast cancer. Cancer 98: 1578–1586
Chan WS, Anand S, Ginsberg JS (2000) Anticoagulation of pregnant women with mechanical heart valves. Arch Intern Med 160: 191– 196
Dahlbäck B (2004) APC resistance: what have we learned since 1993? J Lab Med 28: 21–27
Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, Ray JG (2004) Prevention of venous thromboembolism. 7th ACCP conference on antithrombotic and thrombolytic therapy. Chest 126: 338S–400S
Greer IA; Nelson-Piercy C (2005) Low-molecular weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood 2005; 106 (2): 401–407
Hennessy S, Berlin JA, Kinmann JL, Margolis DJ, Marcus SM, Strom BL (2001) Risk of venous thromboembolism from oral contraceptives containig gestodene and desogestrel versus levonorgestrel: a metaanalysis and formal sensitivity analysis. Contraception 64: 125–133
Karim R, Sacher RA (2004) Thrombocytopenia in pregnancy. Curr Hematol Rep 3: 128–133
Kemkes-Matthes B (2001) Veränderungen des Gerinnungssystems in der Schwangerschaft. Z Kardiol 90: Suppl 4: 45–48
Kemmeren JM, Algra A, Grobbee DE (2001) Third generation oral contraceptives and risk of venous thrombosis: a meta analysis. BMJ 323: 131–134
Koscielny J, von Tempelhoff GF, Ziemer S, Radtke H, Schmutzler M, Sinha P Salama A, Kiesewetter H, Latza R (2004a) A practical concept for pre-operative management of patients with impaired primary hemostasis. Clin Appl Thromb Hemost 10: 155–166
Koscielny J, Ziemer S, Radtke H, Schmutzler M, Pruss A, Sinha P, Salama A, Kiesewetter H, Latza R (2004b) A practical concept for preoperative identification of patients with impaired primary hemostasis. Clin Appl Thromb Hemost 10: 195–204
Kupferminc MJ (2005) Thrombophilia and preeclampsia: The evidence so far. Clin Obstet Gynecol 48: 406–415
Levine JS, Branch DW, Rauch J (2002) The antiphospholipid syndrome. N Engl J Med 346 (10): 752–763
Lindhoff-Last E (2004) Maternal thrombophilia and obstetric complications. J Lab Med 28: 34–41
Lindhoff-Last E, Luxembourg B (2008) Evidenced based indications for thrombophilia screening. VASA 2008; 37 (1): 19–30
Lindhoff-Last E, Kreutzenbeck HJ, Magnani HN (20En) Treatment of 51 pregnancies with danaparoid because of heparin intolerance. Thromb Haemost 93 (1): 63–69
Lindhoff-Last E, Sohn C, Ehrly AM, Bauersachs RM (2000) Aktuelles Management der Thrombembolie in Schwangerschaft und Wochenbett. Zentralbl Gynäkol 122: 4–17
Lindqvist PG, Merlo J (2005) Low molecular weight heparin for repeated pregnancy loss: is it based on solid evidence? J Thromb Haemost 3: 221–223
Lowe GDO, Rumley A, Woodward M, Morrison CE, Philippou H, Lane DA, Tunstall-Pedoe H (1997) Epidemiology of coagulation factors, inhibitors and activation markers: 3rd Glasgow MONICA Survey I. Illustrative reference ranges by age, sex and hormone use. Br J Haematol 97: 775–784
Luxembourg B, Krause M, Lindhoff-Last E (2007) Basiswissen Gerinnungslabor . Dtsch Ärztebl 104 (21): A 1489–1498.
Luxembourg B, Schmitt J, Humpiich M, Glowatzki M, Seifried E, Lindhoff- Last E (2009) Intrinsic clotting factors in dependency of age, sex, body mass index and oral contracetpives: definition and risk of elevated clotting factor levels. Blood Coagul Fibrinolyisis 20 (7): 524–534
Mousa HA, Walkinshaw S (2004) Major postpartum haemorrhage. Curr Opin Obstet Gynecol 123:595–603
Nesheim M (2003) Thrombin and fibrinolysis. Chest 124: 33S–39S
Pengo V, Tripodi A, Reber G, Rand JH, Ortel TL, Galli M, de Groot P (2009) Update of the guidelines for lupus anticoagulant detection. J Thromb Haemost 7: 1737–1740
Petitti DB (2003) Clinical Practice. Combination estrogen-progestin oral contraceptives, N Engl J Med 349: 1443–1450
Rai R, Cohen H, Dave M, Regan L (1997) Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with antiphospholipid antibodies. BMJ 314: 253–257
Rey E, Kahn S, David M et al. (2003) Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 361: 901–908
Provan D, Stasi R, Newland AC et al. (2010) International consensus report on the investigation and management of primary idiopathic thrombocytopenia. Blood 115 (2): 168–186
Schaefer C, Spielmann H (2001) Arzneiverordnung in Schwangerschaft und Stillzeit. Urban & Fischer: München, Jena
Scharrer I (2004) Women with von Willebrand disease. Hämostaseologie 24: 44–49
Shankar M, Lee CA, Sabin CA, Economides DL, Kadir RA (2004) Von Willebrand disease in women with menorrhagia: a systematic review. BJOG 111: 734–740
Willeke A, Gerdsen F, Bauersachs R, Lindhoff-Last E (2002) Rationelle Thrombophilie-Diagnostik. Dtsch Ärztebl 99: A2111–2118
Writing Group for the Women's Health Initiative Investigators (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results form the Women's Health Initiative randomized controlled trial. JAMA 288: 321–333
Writing Group for the Women's Health Initiative Investigators (2004) Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. JAMA 291: 1701–1712
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Lindhoff-Last, E. (2013). Blutungs- und Gerinnungsstörungen. In: Kaufmann, M., Costa, S.D., Scharl, A. (eds) Die Gynäkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-20923-9_16
Download citation
DOI: https://doi.org/10.1007/978-3-642-20923-9_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-20922-2
Online ISBN: 978-3-642-20923-9
eBook Packages: Medicine (German Language)